SlideShare a Scribd company logo
CER Team Meeting: Data
Dictionary Planning
November 12, 2010
Agenda
• Review CER research questions and
hypotheses
– Specific aims of the grant
– Conceptual model
– Refining hypotheses
– Sources of data
• Outline for systematic identification of data
domains and elements
Agenda
• Review CER research questions and
hypotheses
– Specific aims of the grant
– Conceptual model
– Refining hypotheses
– Sources of data
• Outline for systematic identification of data
domains and elements
Specific Aims of the Grant
• Specific Aim Related to CER (Aim 3): Develop
and enhance four sentinel cohort pairs of
patients with asthma (pediatric and adult),
hypertension, and hypercholesterolemia
distinguished by their care delivery
characteristics which can support
comparative effectiveness research.
Specific Aims of the Grant
• Overall Goals:
• Demonstrate the capability of the SAFTINet data
system to collect and accurately link relevant and
valid patient-level information necessary for
comparing the effectiveness of different delivery
system strategies
• Lay the groundwork (cohort identification,
outcomes measurement, sample size estimates,
etc.) to conduct prospective observational studies
and clinical trials
Specific Aims of the Grant
• The SPECIFIC SUB-AIMS for Aim 3 are:
– Specific Aim 3.1 Specify the data elements required
for optimal cohort creation.
– Specific Aim 3.2 Develop and use multivariable
models of asthma, blood pressure and cholesterol
control to identify system-level, individual care
provider-level, and patient-level factors associated
with the control of these conditions.
– Specific Aim 3.3 Enhance the data set by
implementing point-of-care data collection tools for
health-related quality of life.
Agenda
• Review CER research questions and
hypotheses
– Specific aims of the grant
– Conceptual model
– Refining hypotheses
– Sources of data
• Outline for systematic identification of data
domains and elements
Conceptual Model
Relatively
Mutable
CLINICAL INERTIA
Counseling
Drug selection
Dosage selection
Concomitant meds
Follow-up
Decision support
PATIENT-CENTERED
MEDICAL HOME
Integrated Mental
Health Care
Disease-specific case
mngmnt
Access to care
Outcomes feedback
THERAPY ADHERENCE
Therapy persistence
Mental health status
Health knowledge
Perceived need for
care
Symptoms
Drug side effects
PROCESSES OF
CARE
(clinician
factors)
+
STRUCTURES OF
CARE
(system factors)
+ PATIENT FACTORS →
OUTCOMES
(chronic
disease
control)
Relatively
immutable
Appointment time
Patient load
Physical facilities
Practice type
Support personnel
Generalist vs.
specialist
Age
Gender
Race/ethnicity
SES
Marital status
Religious/cultural
beliefs
Comorbidity
Agenda
• Review CER research questions and
hypotheses
– Specific aims of the grant
– Conceptual model
– Refining hypotheses
– Sources of data
• Outline for systematic identification of data
domains and elements
Refining Hypotheses
• Hypothesis from Research Design: “We
hypothesize that health care delivery system
factors, such as the patient-centered medical
home, outweigh individual care provider
factors, patient factors, and medication
effectiveness in the control of asthma, high
blood pressure and hypercholesterolemia. “
Example Hypotheses
• Pediatric asthma outcomes (define) are better by
some amount X (define) at health centers that
implement PCMH functions (define specific
function(s)).
• A greater proportion of adult hypertension patients
with a dx of depression are appropriately controlled
at practices that have integrated mental health
services (IMH).
• The level (intensity) of IMH services is correlated
with improved BP control in adult HTN patients
whom also have a dx of depression.
Refining Hypotheses
CLINICAL INERTIA
Drug selection
Dosage selection
Concomitant meds
PATIENT-CENTERED
MEDICAL HOME
Intgrtd Mental Health
Disease-specific case
management
Access to care
THERAPY ADHERENCE
Therapy persistence
Mental health status
PROCESSES OF
CARE
(clinician factors)
+
STRUCTURES OF
CARE
(system factors)
+ PATIENT FACTORS →
OUTCOMES
(chronic disease
control)
Generalist vs. specialist
Age, Gender
Race/ethnicity
SES
Marital status
Comorbidity
Hypothesis: health care delivery system factors, such as the patient-centered
medical home, outweigh individual care provider factors, patient factors, and
medication effectiveness in the control of asthma, high blood pressure and
hypercholesterolemia.
Refining Hypotheses
PROCESSES OF
CARE
(clinician factors)
+
STRUCTURES OF
CARE
(system factors)
+ PATIENT FACTORS →
OUTCOMES
(chronic disease
control)
•Primary explanatory variable: patient-centered medical home
•Dependent variables: meeting national, evidence-based guidelines
for control
•Independent variables: Factors associated with disease control,
identified from literature, research experience, and clinical
judgment
•Statistical analysis: Mixed effects models will be used to determine
factors associated with chronic disease control; the primary
explanatory variable of the PCMH clinic, and the other factors
impacting chronic disease control
Agenda
• Review CER research questions and
hypotheses
– Specific aims of the grant
– Conceptual model
– Refining hypotheses
– Sources of data
• Sample data dictionary
• Outline for systematic identification of data
domains and elements
Sources of Data
• EHR
• Medicaid claims
• Enhanced point-of-care data collection
• Organizational or practice-level survey
Agenda
• Review CER research questions and
hypotheses
– Specific aims of the grant
– Conceptual model
– Refining hypotheses
– Sources of data
• Sample data dictionary
• Outline for systematic identification of data
domains and elements
Sample Data Dictionary
SAFTINet data dictionary structure
Construct Measure Elements Values Reference Data
Source
Agenda
• Review CER research questions and
hypotheses
– Specific aims of the grant
– Conceptual model
– Refining hypotheses
– Sources of data
• Sample data dictionary
• Outline for systematic identification of data
domains and elements
Outline for Systematic Identification of
Data Domains and Elements
• Establish:
– Hypotheses and research questions
– Cohort definition
– Outcome measures
– Primary explanatory variable
– Covariates
• Establish these in order to:
– Make a list of needed data elements for current work
– Lay the groundwork for future directions
• Document a rationale for hypotheses and
selection of measures (constructs and data
elements)
Outline for Systematic Identification of
Data Domains and Elements
• An example from an asthma cohort
• Purpose of example to illustrate
– Selecting hypotheses and measures
– Listing data elements
– Documentation of a rationale for hypotheses and
selection of measures (constructs and data
elements)
PROCESSES OF
CARE
(clinician factors)
+
STRUCTURES OF
CARE
(system factors)
+ PATIENT FACTORS →
OUTCOMES
(chronic disease
control)
Outline for Systematic Identification of
Data Domains and Elements
• Establish:
– Hypotheses and research questions
– Cohort definition
– Outcome measures
– Primary explanatory variable
– Covariates
• Establish these in order to:
– Make a list of needed data elements for current work
– Lay the groundwork for future directions
• Document a rationale for hypotheses and
selection of measures (constructs and data
elements)
Outline for Systematic Identification of
Data Domains and Elements
•Establish hypothesis: clinical inertia is
associated with worse asthma control
CLINICAL INERTIA
PROCESSES OF
CARE
(clinician factors)
+
STRUCTURES OF
CARE
(system factors)
+ PATIENT FACTORS →
OUTCOMES
(chronic disease
control)
Outline for Systematic Identification of
Data Domains and Elements
•Primary explanatory variable: clinical inertia
•Dependent variables: meeting evidence-based
guidelines for control
•Independent variables: Factors associated with
disease control, identified from literature,
research experience, and clinical judgment
CLINICAL INERTIA
PROCESSES OF
CARE
(clinician factors)
+
STRUCTURES OF
CARE
(system factors)
+ PATIENT FACTORS →
OUTCOMES
(chronic disease
control)
Selection of hypothesis: rationale
Outline for Systematic Identification of
Data Domains and Elements
• Establish:
– Hypotheses and research questions
– Cohort definition
– Outcome measures
– Primary explanatory variable
– Covariates
• Establish these in order to:
– Make a list of needed data elements for current work
– Lay the groundwork for future directions
• Document a rationale for hypotheses and
selection of measures (constructs and data
elements)
Cohort Definition
• Concept: patients with persistent asthma
• Options
– Research Design’s definition
– HEDIS criteria
– Adjusted HEDIS criteria
– Enhanced data collection
– Others
Cohort Definition
• Research Design: “As per the 2007 …EPR-3, we will
define persistent asthma as” > 1 of the following
criteria in 12 months
– > 1 prescriptions for an asthma maintenance therapy
– > 2 asthma-related ED visits
– > 1 asthma-related hospitalization
Cohort Definition
• HEDIS: > 1 of the following criteria in 12 months
– > 4 asthma medication dispensing events
– > 2 asthma medication dispensing events + 4 asthma-related
outpatient visits
– > 1 asthma-related hospitalization
– > 1 asthma-related ED visit
• Adjusted HEDIS criteria: improved validity if patients meeting
criteria for >2 consecutive years (Mosen et al., 2005)
• Enhanced data:
– Patient-entered chronic severity (kiosk) to assess current impairment and
future risk (Porter et al., 2004)
– Provider-entered assessment of severity
Data Elements for Cohort Definition
Construct Measure Elements Values Reference Data
Source
Cohort
definition
HEDIS definition of persistent
asthma 1: > 4 asthma
medication dispensing events in
12 months
Asthma medication
dispensed (date,
medication)
y/n HEDIS
manual
Claims
data
Cohort
definition
HEDIS definition of persistent
asthma 2: > 2 asthma
medication dispensing events +
4 asthma-related outpatient
visits in 12 months
Asthma medication
dispensed (date,
medication)
Asthma-related
outpatient visits
(date, ICD-9 code)
y/n HEDIS
manual
Claims
data
Cohort
definition
HEDIS definition of persistent
asthma 3: > 1 asthma-related
hospitalization in 12 months
Asthma-related
inpatient visits (date,
ICD-9 code)
y/n HEDIS
manual
Claims
data
Cohort
definition
HEDIS definition of persistent
asthma 4: > 1 asthma-related
ED visits in 12 months
Asthma-related ED
visits (date, ICD-9
code)
y/n HEDIS
manual
Claims
data
Rationale for Selection of Measures
The current HEDIS measure for asthma uses administrative data
collected during 1 year to identify patients with presumed
persistent asthma and evaluates controller therapy during the
next year. The current HEDIS asthma inclusion include a
significant portion of patients with intermittent asthma;1, 2 thus,
we chose to use the methods validated by Moser et al., who
adapted the HEDIS measure to require at least 2 consecutive
years meeting qualification criteria to identify persistent
asthma.3
1 Kozyrskyj AL, Mustard CA, Becker AB. Identifying children with persistent asthma
from health care administrative records. Can Respir J. 2004;11:141-145.
2 Cabana MD, Slish KK, Nan B, Clark NM. Limits of the HEDIS criteria in determining
asthma severity for children. Pediatrics. 2004;114:1049-1055.
3 Mosen DM, Macy E, Schatz M, et al. How well do the HEDIS asthma inclusion criteria
identify persistent asthma? Am J Manag Care. 2005 Oct;11(10):650-4.
Outline for Systematic Identification of
Data Domains and Elements
• Review
– Hypotheses and research questions
– Cohort definition
– Outcome measures
– Primary explanatory variable
– Covariates
– Other future directions
• Review these in order to
– Make a list of needed data elements for current work
– Lay the groundwork for future directions
Outcome Measures
• Patient-Reported Control Measures
• Utilization Measures
• Health-Related Quality-of-Life (HRQoL)
PROCESSES OF
CARE
(clinician factors)
+
STRUCTURES OF
CARE
(system factors)
+ PATIENT FACTORS →
OUTCOMES
(chronic disease
control)
• Asthma Control Test (ACT) (Nathan et al. 2004)
• Childhood Asthma Control Test (Liu et al.
2007)
• Asthma Control Questionnaire (Juniper et al.
1999)
• Asthma Therapy Assessment Questionnaire
(ATAQ) control index (Vollmer et al. 1999) –
mentioned in Research Design
Patient-Reported Control Measures
Outcome Measures: Utilization Measures
• Ratio of controller to total asthma medications—
mentioned in Research Design
– > 0.5 is suggested cut-point
– better associated with utilization (ED visits) than is
HEDIS outcome measure
– Weighted vs. not
• HEDIS outcome measure
– prescription of at least one controller medication
– found to be more of a severity indicator than
quality/control measure
• Acute hospital visits (ED, inpatient)
Outcome Measures: HRQoL
• Asthma-Specific Quality of Life
– Mini Asthma Quality of Life Questionnaire (Juniper et
al. 1999a)
– Asthma Quality of Life Questionnaire (Katz et al. 1999;
Marks et al. 1993)
– ITG Asthma Short Form (Bayliss et al. 2000)
– Asthma Quality of Life for Children (Juniper et al.
1996)
– Others?
• Generic Quality of Life
– SF-36 (Bousquet et al. 1994)
– SF-12 (Ware et al. 1996)
Data Elements for Outcome Measures
Definition
Construct Measure Elements Values Reference Data
Source
Asthma
control
Childhood Asthma Control Test 7 components 0-27
(poor
control
<19)
Liu et al.
2007
POC
measure
Asthma
control
Ratio of controller to total
asthma medications
Asthma medication
dispensed (date,
medication)
0-1
(dichot
omize
at 0.5)
HEDIS
manual
Claims
data
Asthma
control
Acute hospital resource
utilization
Asthma-related
inpatient visits (date,
ICD-9 code)
# visits Claims
data
Asthma
control
Acute hospital resource
utilization
Asthma-related ED
visits (date, ICD-9
code)
# visits Claims
data
Rationale for Selection of Measures
Outline for Systematic Identification of
Data Domains and Elements
• Establish:
– Hypotheses and research questions
– Cohort definition
– Outcome measures
– Primary explanatory variable
– Covariates
• Establish these in order to:
– Make a list of needed data elements for current work
– Lay the groundwork for future directions
• Document a rationale for hypotheses and
selection of measures (constructs and data
elements)
Primary Explanatory Variable
• Clinical inertia: “the failure of clinicians to
initiate or intensify drug therapy appropriately
in a patient with uncontrolled asthma, blood
pressure or cholesterol”
CLINICAL INERTIA
PROCESSES OF
CARE
(clinician factors)
+
STRUCTURES OF
CARE
(system factors)
+ PATIENT FACTORS →
OUTCOMES
(chronic disease
control)
Guideline-concordant
intensification steps
• Intensify =
follow EPR3
steps
• Uncontrolled
= based on
POC control
test (ACT,
ATAQ, etc)
Data Elements for Primary Explanatory
Variable Definition
Construct Measure Elements Values Reference Data
Source
Clinical
inertia
Childhood Asthma Control Test 7 components, date 0-27
(poor
control
<19)
Liu et al.
2007
POC
measure
Clinical
inertia
Medications Asthma medication
dispensed (date,
medication)
Claims
data
Rationale for Selection of Measures
???
Outline for Systematic Identification of
Data Domains and Elements
• Establish:
– Hypotheses and research questions
– Cohort definition
– Outcome measures
– Primary explanatory variable
– Covariates
• Establish these in order to:
– Make a list of needed data elements for current work
– Lay the groundwork for future directions
• Document a rationale for hypotheses and
selection of measures (constructs and data
elements)
Covariates
• Processes of Care
– Clinical inertia (primary
explanatory variable)
– Medication prescription
• Structures of Care
– Practice demographics
– PCMH, IMH
PROCESSES OF
CARE
(clinician factors)
+
STRUCTURES OF
CARE
(system factors)
+ PATIENT FACTORS →
OUTCOMES
(chronic disease
control)
• Patient Factors
– Demographics, access
– Co-morbidity (medical,
mental health)
– Severity of illness
– Therapy adherence
Covariates
• Processes of Care
– Clinical inertia (primary
explanatory variable)
– Medication prescription
• Structures of Care
– Practice demographics
– PCMH, IMH
PROCESSES OF
CARE
(clinician factors)
+
STRUCTURES OF
CARE
(system factors)
+ PATIENT FACTORS →
OUTCOMES
(chronic disease
control)
• Patient Factors
– Demographics, access
– Co-morbidity (medical,
mental health)
– Severity of illness
– Therapy adherence
Covariates
• Medical Comorbidity:
– “Chronic medical co-morbidity will be...grouped
into 30 comorbidities as described by Elixhauser
and Quan.” (AHRQ co-morbidity measures)
– Body Mass Index (do we need other measures for
children?)
– Smoking status (also 2nd hand smoke exposure?)
PROCESSES OF
CARE
(clinician factors)
+
STRUCTURES OF
CARE
(system factors)
+ PATIENT FACTORS →
OUTCOMES
(chronic disease
control)
Comorbidity
AHRQ comorbidity measures
Data Elements for Comorbidity
Variable Definition
Construct Measure Elements Values Reference Data
Source
Medical
co-
morbidity
HCUP comorbidity measure ICD-9 codes from
encounters and
problem list
0-27
(poor
control
<19)
Liu et al.
2007
EHR
Rationale
Disease-specific discussions
• Hypertension
• Hyperlipidemia
• Asthma (Peds)
• Asthma (Adults)
Outline for Systematic Identification of
Data Domains and Elements
• Establish:
– Hypotheses and research questions
– Cohort definition
– Outcome measures
– Primary explanatory variable
– Covariates
• Establish these in order to:
– Make a list of needed data elements for current work
– Lay the groundwork for future directions
• Documenting a rationale for hypotheses and
selection of measures (constructs and data
elements)
Hypertension
• Hypotheses:
Hypertension
• Cohort definition:
Hypertension
• Outcome measures:
Hypertension
• Covariates:
Structures of Care
• PCMH
• IMH
Patient Centered Med Home
Standards- NCQA
1. Access and Communication
2. Patient Tracking and Registry Functions
3. Care Management
4. Patient Self‐Management Support
5. Electronic Prescribing
6. Test Tracking
7. Referral Tracking
8. Performance Reporting and Improvement
9. Advanced Electronic Communications
Integrated Mental Health
• ????
Disease-specific PCMH/IMH
Factors
• E.g., Asthma educators?
System Level Factors
• Applied differently based on
patient/family/doctor-- can we account for
this or not??
Considerations for Future Research
Asthma:
• Asthma epidemiology has focused on individual-
level and family risk factors.
• Less focus on social and environmental context.
• Low-income individuals more likely to be exposed
to irritants, pollutants, indoor allergens, and
psychosocial stress, which may influence asthma
morbidity.
• Future vision: enhance our cohort with data on
suspected biological and environmental
determinants of asthma disparities.
Considerations for Future Research
Hypertension:
• Prevalence and rate of diagnosis of hypertension
in children and adolescents are increasing, due in
part to the increasing obesity prevalence and
growing awareness of hypertension.
• Future vision: expand our cohort to include
adolescents with hypertension in an effort to
identify health care delivery strategies
appropriate for the lifespan of patients with
hypertension.
Considerations for Future Research
Hypercholesterolemia:
• American Academy of Pediatrics recommends
screening overweight children with a fasting
lipid profile
• Rising obesity epidemic in U.S. children
• Future vision: expand our
hypercholesterolemia cohort to include
overweight children.
Research team meeting mrs

More Related Content

What's hot

What Is Evidence Based Practice
What Is Evidence Based Practice What Is Evidence Based Practice
What Is Evidence Based Practice
Virginia Commonwealth University
 
Systematic Reviews: Context & Methodology for Librarians
Systematic Reviews: Context & Methodology for LibrariansSystematic Reviews: Context & Methodology for Librarians
Systematic Reviews: Context & Methodology for Librarians
University of Michigan Taubman Health Sciences Library
 
systematic review : why & How
systematic review : why & Howsystematic review : why & How
systematic review : why & How
Hesham Al-Inany
 
Introduction to systematic reviews
Introduction to systematic reviewsIntroduction to systematic reviews
Introduction to systematic reviews
Omar Midani
 
Systematic reviews
Systematic reviewsSystematic reviews
Systematic reviews
Lydia Pyburn
 
Systematic Reviews in the Health Sciences
Systematic Reviews in the Health SciencesSystematic Reviews in the Health Sciences
Systematic Reviews in the Health Sciences
Becky Morin
 
Ebp Lab Sum 09 A (2)
Ebp Lab Sum 09 A (2)Ebp Lab Sum 09 A (2)
Ebp Lab Sum 09 A (2)CCCLibrary
 
Healthcare analytics
Healthcare analytics Healthcare analytics
Healthcare analytics
Arun K
 
Malimu research protocol
Malimu research protocolMalimu research protocol
Malimu research protocol
Miharbi Ignasm
 
Introduction to Research methodology
Introduction to Research methodology Introduction to Research methodology
Introduction to Research methodology
International Islamic University Malaysia
 
Protocol writing
Protocol writingProtocol writing
Protocol writing
Dr.Amreen Saba Attariya
 
Systematic Reviews: the researcher's perspective and the research question. E...
Systematic Reviews: the researcher's perspective and the research question. E...Systematic Reviews: the researcher's perspective and the research question. E...
Systematic Reviews: the researcher's perspective and the research question. E...
healthlibaust2012
 
Literature review basics
Literature review basicsLiterature review basics
Literature review basicsJames B
 
Nursing Research Designs
Nursing Research DesignsNursing Research Designs
Nursing Research Designs
Bgomathi Mahalingam
 
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
healthlibaust2012
 
Research Methodology
Research Methodology Research Methodology
Research Methodology
Deepak Basyal
 
J.1756 5391.2010.01087.x
J.1756 5391.2010.01087.xJ.1756 5391.2010.01087.x
J.1756 5391.2010.01087.xMWasser6
 
Introduction to nursing research
Introduction to nursing researchIntroduction to nursing research
Introduction to nursing research
Eko Priyanto
 
The EQ-5D and Its Use Internationally
The EQ-5D and Its Use InternationallyThe EQ-5D and Its Use Internationally
The EQ-5D and Its Use Internationally
Office of Health Economics
 
Research methodology
Research methodologyResearch methodology
Research methodology
SantoshKumar2146
 

What's hot (20)

What Is Evidence Based Practice
What Is Evidence Based Practice What Is Evidence Based Practice
What Is Evidence Based Practice
 
Systematic Reviews: Context & Methodology for Librarians
Systematic Reviews: Context & Methodology for LibrariansSystematic Reviews: Context & Methodology for Librarians
Systematic Reviews: Context & Methodology for Librarians
 
systematic review : why & How
systematic review : why & Howsystematic review : why & How
systematic review : why & How
 
Introduction to systematic reviews
Introduction to systematic reviewsIntroduction to systematic reviews
Introduction to systematic reviews
 
Systematic reviews
Systematic reviewsSystematic reviews
Systematic reviews
 
Systematic Reviews in the Health Sciences
Systematic Reviews in the Health SciencesSystematic Reviews in the Health Sciences
Systematic Reviews in the Health Sciences
 
Ebp Lab Sum 09 A (2)
Ebp Lab Sum 09 A (2)Ebp Lab Sum 09 A (2)
Ebp Lab Sum 09 A (2)
 
Healthcare analytics
Healthcare analytics Healthcare analytics
Healthcare analytics
 
Malimu research protocol
Malimu research protocolMalimu research protocol
Malimu research protocol
 
Introduction to Research methodology
Introduction to Research methodology Introduction to Research methodology
Introduction to Research methodology
 
Protocol writing
Protocol writingProtocol writing
Protocol writing
 
Systematic Reviews: the researcher's perspective and the research question. E...
Systematic Reviews: the researcher's perspective and the research question. E...Systematic Reviews: the researcher's perspective and the research question. E...
Systematic Reviews: the researcher's perspective and the research question. E...
 
Literature review basics
Literature review basicsLiterature review basics
Literature review basics
 
Nursing Research Designs
Nursing Research DesignsNursing Research Designs
Nursing Research Designs
 
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
Systematic Reviews: the process, quantitative, qualitative and mixed methods ...
 
Research Methodology
Research Methodology Research Methodology
Research Methodology
 
J.1756 5391.2010.01087.x
J.1756 5391.2010.01087.xJ.1756 5391.2010.01087.x
J.1756 5391.2010.01087.x
 
Introduction to nursing research
Introduction to nursing researchIntroduction to nursing research
Introduction to nursing research
 
The EQ-5D and Its Use Internationally
The EQ-5D and Its Use InternationallyThe EQ-5D and Its Use Internationally
The EQ-5D and Its Use Internationally
 
Research methodology
Research methodologyResearch methodology
Research methodology
 

Similar to Research team meeting mrs

Meps secondary data analysis talk 20080806
Meps secondary data analysis talk 20080806Meps secondary data analysis talk 20080806
Meps secondary data analysis talk 20080806
Marion Sills
 
RCT CH0.ppt
RCT CH0.pptRCT CH0.ppt
RCT CH0.ppt
Abebe334138
 
RCT CH0.ppt
RCT CH0.pptRCT CH0.ppt
RCT CH0.ppt
AbebeNega
 
Hm 418 harris ch12 ppt
Hm 418 harris ch12 pptHm 418 harris ch12 ppt
Hm 418 harris ch12 ppt
BealCollegeOnline
 
Edm forum virtual brown bag presentation
Edm forum virtual brown bag presentationEdm forum virtual brown bag presentation
Edm forum virtual brown bag presentation
Marion Sills
 
Knowledge discovery in medicine
Knowledge discovery in medicineKnowledge discovery in medicine
Knowledge discovery in medicine
Avinash Hanwate
 
Methods for Observational Comparative Effectiveness Research on Healthcare De...
Methods for Observational Comparative Effectiveness Research on Healthcare De...Methods for Observational Comparative Effectiveness Research on Healthcare De...
Methods for Observational Comparative Effectiveness Research on Healthcare De...
Marion Sills
 
Computer validation of e-source and EHR in clinical trials-Kuchinke
Computer validation of e-source and EHR in clinical trials-KuchinkeComputer validation of e-source and EHR in clinical trials-Kuchinke
Computer validation of e-source and EHR in clinical trials-Kuchinke
Wolfgang Kuchinke
 
Computer System Validation - privacy zones, eSource and EHR data in clinical ...
Computer System Validation - privacy zones, eSource and EHR data in clinical ...Computer System Validation - privacy zones, eSource and EHR data in clinical ...
Computer System Validation - privacy zones, eSource and EHR data in clinical ...
Wolfgang Kuchinke
 
Computer System Validation with privacy zones, e-source and clinical trials b...
Computer System Validation with privacy zones, e-source and clinical trials b...Computer System Validation with privacy zones, e-source and clinical trials b...
Computer System Validation with privacy zones, e-source and clinical trials b...
Wolfgang Kuchinke
 
Routine data use in evaluation: practical guidance
Routine data use in evaluation: practical guidanceRoutine data use in evaluation: practical guidance
Routine data use in evaluation: practical guidance
MEASURE Evaluation
 
Clinical Research Informatics Year-in-Review
Clinical Research Informatics Year-in-ReviewClinical Research Informatics Year-in-Review
Clinical Research Informatics Year-in-Review
Peter Embi
 
Surgical Audit & Research
Surgical Audit & ResearchSurgical Audit & Research
Surgical Audit & Research
Dr Mubashir Bashir
 
Operations research within UK healthcare: A review
Operations research within UK healthcare: A reviewOperations research within UK healthcare: A review
Operations research within UK healthcare: A review
Harender Singh
 
Embi cri yir-2017-final
Embi cri yir-2017-finalEmbi cri yir-2017-final
Embi cri yir-2017-final
Peter Embi
 
Data mining (DM) in the pharmaceutical industry
Data mining (DM) in the pharmaceutical industryData mining (DM) in the pharmaceutical industry
Data mining (DM) in the pharmaceutical industry
lurdhu agnes
 
Evidence based orthodontics parag
Evidence based orthodontics paragEvidence based orthodontics parag
Evidence based orthodontics parag
Parag Deshmukh
 
HM404 Ab120916 ch11
HM404 Ab120916 ch11HM404 Ab120916 ch11
HM404 Ab120916 ch11
BealCollegeOnline
 
SystematicreviewJan2017.pptx
SystematicreviewJan2017.pptxSystematicreviewJan2017.pptx
SystematicreviewJan2017.pptx
ssuserf2f9e1
 
Aea presentation final 18_oct2013
Aea presentation final 18_oct2013Aea presentation final 18_oct2013
Aea presentation final 18_oct2013soder145
 

Similar to Research team meeting mrs (20)

Meps secondary data analysis talk 20080806
Meps secondary data analysis talk 20080806Meps secondary data analysis talk 20080806
Meps secondary data analysis talk 20080806
 
RCT CH0.ppt
RCT CH0.pptRCT CH0.ppt
RCT CH0.ppt
 
RCT CH0.ppt
RCT CH0.pptRCT CH0.ppt
RCT CH0.ppt
 
Hm 418 harris ch12 ppt
Hm 418 harris ch12 pptHm 418 harris ch12 ppt
Hm 418 harris ch12 ppt
 
Edm forum virtual brown bag presentation
Edm forum virtual brown bag presentationEdm forum virtual brown bag presentation
Edm forum virtual brown bag presentation
 
Knowledge discovery in medicine
Knowledge discovery in medicineKnowledge discovery in medicine
Knowledge discovery in medicine
 
Methods for Observational Comparative Effectiveness Research on Healthcare De...
Methods for Observational Comparative Effectiveness Research on Healthcare De...Methods for Observational Comparative Effectiveness Research on Healthcare De...
Methods for Observational Comparative Effectiveness Research on Healthcare De...
 
Computer validation of e-source and EHR in clinical trials-Kuchinke
Computer validation of e-source and EHR in clinical trials-KuchinkeComputer validation of e-source and EHR in clinical trials-Kuchinke
Computer validation of e-source and EHR in clinical trials-Kuchinke
 
Computer System Validation - privacy zones, eSource and EHR data in clinical ...
Computer System Validation - privacy zones, eSource and EHR data in clinical ...Computer System Validation - privacy zones, eSource and EHR data in clinical ...
Computer System Validation - privacy zones, eSource and EHR data in clinical ...
 
Computer System Validation with privacy zones, e-source and clinical trials b...
Computer System Validation with privacy zones, e-source and clinical trials b...Computer System Validation with privacy zones, e-source and clinical trials b...
Computer System Validation with privacy zones, e-source and clinical trials b...
 
Routine data use in evaluation: practical guidance
Routine data use in evaluation: practical guidanceRoutine data use in evaluation: practical guidance
Routine data use in evaluation: practical guidance
 
Clinical Research Informatics Year-in-Review
Clinical Research Informatics Year-in-ReviewClinical Research Informatics Year-in-Review
Clinical Research Informatics Year-in-Review
 
Surgical Audit & Research
Surgical Audit & ResearchSurgical Audit & Research
Surgical Audit & Research
 
Operations research within UK healthcare: A review
Operations research within UK healthcare: A reviewOperations research within UK healthcare: A review
Operations research within UK healthcare: A review
 
Embi cri yir-2017-final
Embi cri yir-2017-finalEmbi cri yir-2017-final
Embi cri yir-2017-final
 
Data mining (DM) in the pharmaceutical industry
Data mining (DM) in the pharmaceutical industryData mining (DM) in the pharmaceutical industry
Data mining (DM) in the pharmaceutical industry
 
Evidence based orthodontics parag
Evidence based orthodontics paragEvidence based orthodontics parag
Evidence based orthodontics parag
 
HM404 Ab120916 ch11
HM404 Ab120916 ch11HM404 Ab120916 ch11
HM404 Ab120916 ch11
 
SystematicreviewJan2017.pptx
SystematicreviewJan2017.pptxSystematicreviewJan2017.pptx
SystematicreviewJan2017.pptx
 
Aea presentation final 18_oct2013
Aea presentation final 18_oct2013Aea presentation final 18_oct2013
Aea presentation final 18_oct2013
 

More from Marion Sills

Measuring and Enhancing Your Academic Medical Impact
Measuring and Enhancing Your Academic Medical ImpactMeasuring and Enhancing Your Academic Medical Impact
Measuring and Enhancing Your Academic Medical Impact
Marion Sills
 
Social Media for CU's Division of Pediatric Emergency Medicine
Social Media for CU's Division of Pediatric Emergency MedicineSocial Media for CU's Division of Pediatric Emergency Medicine
Social Media for CU's Division of Pediatric Emergency Medicine
Marion Sills
 
Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...
Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...
Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...
Marion Sills
 
ED abdominal pain lecture
ED abdominal pain lectureED abdominal pain lecture
ED abdominal pain lecture
Marion Sills
 
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Marion Sills
 
2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.
2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.
2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.
Marion Sills
 
2014 0423 rqi meeting uds 2.0 and convocation project ideas
2014 0423 rqi meeting uds 2.0 and convocation project ideas2014 0423 rqi meeting uds 2.0 and convocation project ideas
2014 0423 rqi meeting uds 2.0 and convocation project ideas
Marion Sills
 
Practice Variability in and Correlates of Patient-Centered Medical Home Chara...
Practice Variability in and Correlates of Patient-Centered Medical Home Chara...Practice Variability in and Correlates of Patient-Centered Medical Home Chara...
Practice Variability in and Correlates of Patient-Centered Medical Home Chara...
Marion Sills
 
SAFTINet CER Asthma Protocol
SAFTINet CER Asthma ProtocolSAFTINet CER Asthma Protocol
SAFTINet CER Asthma Protocol
Marion Sills
 
CEMRC H1N1 Presentation 20100614
CEMRC H1N1 Presentation 20100614CEMRC H1N1 Presentation 20100614
CEMRC H1N1 Presentation 20100614
Marion Sills
 
SAFTINet Overview for EDRC
SAFTINet Overview for EDRCSAFTINet Overview for EDRC
SAFTINet Overview for EDRC
Marion Sills
 
Patient-reported outcomes for asthma in children and adults
Patient-reported outcomes for asthma in children and adultsPatient-reported outcomes for asthma in children and adults
Patient-reported outcomes for asthma in children and adults
Marion Sills
 
Implementing Point-of-Care PROMs
Implementing Point-of-Care PROMsImplementing Point-of-Care PROMs
Implementing Point-of-Care PROMs
Marion Sills
 
Pec cv pro workgroup 3 21 12
Pec cv pro workgroup 3 21 12Pec cv pro workgroup 3 21 12
Pec cv pro workgroup 3 21 12
Marion Sills
 
ACT Implementation in SAFTINet
ACT Implementation in SAFTINetACT Implementation in SAFTINet
ACT Implementation in SAFTINet
Marion Sills
 
Cv pro overview 2 may 2012
Cv pro overview 2 may 2012Cv pro overview 2 may 2012
Cv pro overview 2 may 2012
Marion Sills
 
Med adherence 2 july 2012
Med adherence 2 july 2012Med adherence 2 july 2012
Med adherence 2 july 2012
Marion Sills
 
Med adherence and self efficacy
Med adherence and self efficacyMed adherence and self efficacy
Med adherence and self efficacy
Marion Sills
 
Cer safti net overview edrc 1 feb 2011
Cer safti net overview edrc 1 feb 2011Cer safti net overview edrc 1 feb 2011
Cer safti net overview edrc 1 feb 2011
Marion Sills
 
Pec research overview 19 jan2011
Pec research overview 19 jan2011Pec research overview 19 jan2011
Pec research overview 19 jan2011
Marion Sills
 

More from Marion Sills (20)

Measuring and Enhancing Your Academic Medical Impact
Measuring and Enhancing Your Academic Medical ImpactMeasuring and Enhancing Your Academic Medical Impact
Measuring and Enhancing Your Academic Medical Impact
 
Social Media for CU's Division of Pediatric Emergency Medicine
Social Media for CU's Division of Pediatric Emergency MedicineSocial Media for CU's Division of Pediatric Emergency Medicine
Social Media for CU's Division of Pediatric Emergency Medicine
 
Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...
Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...
Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...
 
ED abdominal pain lecture
ED abdominal pain lectureED abdominal pain lecture
ED abdominal pain lecture
 
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
 
2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.
2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.
2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.
 
2014 0423 rqi meeting uds 2.0 and convocation project ideas
2014 0423 rqi meeting uds 2.0 and convocation project ideas2014 0423 rqi meeting uds 2.0 and convocation project ideas
2014 0423 rqi meeting uds 2.0 and convocation project ideas
 
Practice Variability in and Correlates of Patient-Centered Medical Home Chara...
Practice Variability in and Correlates of Patient-Centered Medical Home Chara...Practice Variability in and Correlates of Patient-Centered Medical Home Chara...
Practice Variability in and Correlates of Patient-Centered Medical Home Chara...
 
SAFTINet CER Asthma Protocol
SAFTINet CER Asthma ProtocolSAFTINet CER Asthma Protocol
SAFTINet CER Asthma Protocol
 
CEMRC H1N1 Presentation 20100614
CEMRC H1N1 Presentation 20100614CEMRC H1N1 Presentation 20100614
CEMRC H1N1 Presentation 20100614
 
SAFTINet Overview for EDRC
SAFTINet Overview for EDRCSAFTINet Overview for EDRC
SAFTINet Overview for EDRC
 
Patient-reported outcomes for asthma in children and adults
Patient-reported outcomes for asthma in children and adultsPatient-reported outcomes for asthma in children and adults
Patient-reported outcomes for asthma in children and adults
 
Implementing Point-of-Care PROMs
Implementing Point-of-Care PROMsImplementing Point-of-Care PROMs
Implementing Point-of-Care PROMs
 
Pec cv pro workgroup 3 21 12
Pec cv pro workgroup 3 21 12Pec cv pro workgroup 3 21 12
Pec cv pro workgroup 3 21 12
 
ACT Implementation in SAFTINet
ACT Implementation in SAFTINetACT Implementation in SAFTINet
ACT Implementation in SAFTINet
 
Cv pro overview 2 may 2012
Cv pro overview 2 may 2012Cv pro overview 2 may 2012
Cv pro overview 2 may 2012
 
Med adherence 2 july 2012
Med adherence 2 july 2012Med adherence 2 july 2012
Med adherence 2 july 2012
 
Med adherence and self efficacy
Med adherence and self efficacyMed adherence and self efficacy
Med adherence and self efficacy
 
Cer safti net overview edrc 1 feb 2011
Cer safti net overview edrc 1 feb 2011Cer safti net overview edrc 1 feb 2011
Cer safti net overview edrc 1 feb 2011
 
Pec research overview 19 jan2011
Pec research overview 19 jan2011Pec research overview 19 jan2011
Pec research overview 19 jan2011
 

Recently uploaded

Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
Top-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptxTop-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptx
SwisschemDerma
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 

Recently uploaded (20)

Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
Top-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptxTop-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 

Research team meeting mrs

  • 1. CER Team Meeting: Data Dictionary Planning November 12, 2010
  • 2. Agenda • Review CER research questions and hypotheses – Specific aims of the grant – Conceptual model – Refining hypotheses – Sources of data • Outline for systematic identification of data domains and elements
  • 3. Agenda • Review CER research questions and hypotheses – Specific aims of the grant – Conceptual model – Refining hypotheses – Sources of data • Outline for systematic identification of data domains and elements
  • 4. Specific Aims of the Grant • Specific Aim Related to CER (Aim 3): Develop and enhance four sentinel cohort pairs of patients with asthma (pediatric and adult), hypertension, and hypercholesterolemia distinguished by their care delivery characteristics which can support comparative effectiveness research.
  • 5. Specific Aims of the Grant • Overall Goals: • Demonstrate the capability of the SAFTINet data system to collect and accurately link relevant and valid patient-level information necessary for comparing the effectiveness of different delivery system strategies • Lay the groundwork (cohort identification, outcomes measurement, sample size estimates, etc.) to conduct prospective observational studies and clinical trials
  • 6. Specific Aims of the Grant • The SPECIFIC SUB-AIMS for Aim 3 are: – Specific Aim 3.1 Specify the data elements required for optimal cohort creation. – Specific Aim 3.2 Develop and use multivariable models of asthma, blood pressure and cholesterol control to identify system-level, individual care provider-level, and patient-level factors associated with the control of these conditions. – Specific Aim 3.3 Enhance the data set by implementing point-of-care data collection tools for health-related quality of life.
  • 7. Agenda • Review CER research questions and hypotheses – Specific aims of the grant – Conceptual model – Refining hypotheses – Sources of data • Outline for systematic identification of data domains and elements
  • 8. Conceptual Model Relatively Mutable CLINICAL INERTIA Counseling Drug selection Dosage selection Concomitant meds Follow-up Decision support PATIENT-CENTERED MEDICAL HOME Integrated Mental Health Care Disease-specific case mngmnt Access to care Outcomes feedback THERAPY ADHERENCE Therapy persistence Mental health status Health knowledge Perceived need for care Symptoms Drug side effects PROCESSES OF CARE (clinician factors) + STRUCTURES OF CARE (system factors) + PATIENT FACTORS → OUTCOMES (chronic disease control) Relatively immutable Appointment time Patient load Physical facilities Practice type Support personnel Generalist vs. specialist Age Gender Race/ethnicity SES Marital status Religious/cultural beliefs Comorbidity
  • 9. Agenda • Review CER research questions and hypotheses – Specific aims of the grant – Conceptual model – Refining hypotheses – Sources of data • Outline for systematic identification of data domains and elements
  • 10. Refining Hypotheses • Hypothesis from Research Design: “We hypothesize that health care delivery system factors, such as the patient-centered medical home, outweigh individual care provider factors, patient factors, and medication effectiveness in the control of asthma, high blood pressure and hypercholesterolemia. “
  • 11. Example Hypotheses • Pediatric asthma outcomes (define) are better by some amount X (define) at health centers that implement PCMH functions (define specific function(s)). • A greater proportion of adult hypertension patients with a dx of depression are appropriately controlled at practices that have integrated mental health services (IMH). • The level (intensity) of IMH services is correlated with improved BP control in adult HTN patients whom also have a dx of depression.
  • 12. Refining Hypotheses CLINICAL INERTIA Drug selection Dosage selection Concomitant meds PATIENT-CENTERED MEDICAL HOME Intgrtd Mental Health Disease-specific case management Access to care THERAPY ADHERENCE Therapy persistence Mental health status PROCESSES OF CARE (clinician factors) + STRUCTURES OF CARE (system factors) + PATIENT FACTORS → OUTCOMES (chronic disease control) Generalist vs. specialist Age, Gender Race/ethnicity SES Marital status Comorbidity Hypothesis: health care delivery system factors, such as the patient-centered medical home, outweigh individual care provider factors, patient factors, and medication effectiveness in the control of asthma, high blood pressure and hypercholesterolemia.
  • 13. Refining Hypotheses PROCESSES OF CARE (clinician factors) + STRUCTURES OF CARE (system factors) + PATIENT FACTORS → OUTCOMES (chronic disease control) •Primary explanatory variable: patient-centered medical home •Dependent variables: meeting national, evidence-based guidelines for control •Independent variables: Factors associated with disease control, identified from literature, research experience, and clinical judgment •Statistical analysis: Mixed effects models will be used to determine factors associated with chronic disease control; the primary explanatory variable of the PCMH clinic, and the other factors impacting chronic disease control
  • 14. Agenda • Review CER research questions and hypotheses – Specific aims of the grant – Conceptual model – Refining hypotheses – Sources of data • Sample data dictionary • Outline for systematic identification of data domains and elements
  • 15. Sources of Data • EHR • Medicaid claims • Enhanced point-of-care data collection • Organizational or practice-level survey
  • 16. Agenda • Review CER research questions and hypotheses – Specific aims of the grant – Conceptual model – Refining hypotheses – Sources of data • Sample data dictionary • Outline for systematic identification of data domains and elements
  • 18. SAFTINet data dictionary structure Construct Measure Elements Values Reference Data Source
  • 19. Agenda • Review CER research questions and hypotheses – Specific aims of the grant – Conceptual model – Refining hypotheses – Sources of data • Sample data dictionary • Outline for systematic identification of data domains and elements
  • 20. Outline for Systematic Identification of Data Domains and Elements • Establish: – Hypotheses and research questions – Cohort definition – Outcome measures – Primary explanatory variable – Covariates • Establish these in order to: – Make a list of needed data elements for current work – Lay the groundwork for future directions • Document a rationale for hypotheses and selection of measures (constructs and data elements)
  • 21. Outline for Systematic Identification of Data Domains and Elements • An example from an asthma cohort • Purpose of example to illustrate – Selecting hypotheses and measures – Listing data elements – Documentation of a rationale for hypotheses and selection of measures (constructs and data elements) PROCESSES OF CARE (clinician factors) + STRUCTURES OF CARE (system factors) + PATIENT FACTORS → OUTCOMES (chronic disease control)
  • 22. Outline for Systematic Identification of Data Domains and Elements • Establish: – Hypotheses and research questions – Cohort definition – Outcome measures – Primary explanatory variable – Covariates • Establish these in order to: – Make a list of needed data elements for current work – Lay the groundwork for future directions • Document a rationale for hypotheses and selection of measures (constructs and data elements)
  • 23. Outline for Systematic Identification of Data Domains and Elements •Establish hypothesis: clinical inertia is associated with worse asthma control CLINICAL INERTIA PROCESSES OF CARE (clinician factors) + STRUCTURES OF CARE (system factors) + PATIENT FACTORS → OUTCOMES (chronic disease control)
  • 24. Outline for Systematic Identification of Data Domains and Elements •Primary explanatory variable: clinical inertia •Dependent variables: meeting evidence-based guidelines for control •Independent variables: Factors associated with disease control, identified from literature, research experience, and clinical judgment CLINICAL INERTIA PROCESSES OF CARE (clinician factors) + STRUCTURES OF CARE (system factors) + PATIENT FACTORS → OUTCOMES (chronic disease control)
  • 26. Outline for Systematic Identification of Data Domains and Elements • Establish: – Hypotheses and research questions – Cohort definition – Outcome measures – Primary explanatory variable – Covariates • Establish these in order to: – Make a list of needed data elements for current work – Lay the groundwork for future directions • Document a rationale for hypotheses and selection of measures (constructs and data elements)
  • 27. Cohort Definition • Concept: patients with persistent asthma • Options – Research Design’s definition – HEDIS criteria – Adjusted HEDIS criteria – Enhanced data collection – Others
  • 28. Cohort Definition • Research Design: “As per the 2007 …EPR-3, we will define persistent asthma as” > 1 of the following criteria in 12 months – > 1 prescriptions for an asthma maintenance therapy – > 2 asthma-related ED visits – > 1 asthma-related hospitalization
  • 29. Cohort Definition • HEDIS: > 1 of the following criteria in 12 months – > 4 asthma medication dispensing events – > 2 asthma medication dispensing events + 4 asthma-related outpatient visits – > 1 asthma-related hospitalization – > 1 asthma-related ED visit • Adjusted HEDIS criteria: improved validity if patients meeting criteria for >2 consecutive years (Mosen et al., 2005) • Enhanced data: – Patient-entered chronic severity (kiosk) to assess current impairment and future risk (Porter et al., 2004) – Provider-entered assessment of severity
  • 30. Data Elements for Cohort Definition Construct Measure Elements Values Reference Data Source Cohort definition HEDIS definition of persistent asthma 1: > 4 asthma medication dispensing events in 12 months Asthma medication dispensed (date, medication) y/n HEDIS manual Claims data Cohort definition HEDIS definition of persistent asthma 2: > 2 asthma medication dispensing events + 4 asthma-related outpatient visits in 12 months Asthma medication dispensed (date, medication) Asthma-related outpatient visits (date, ICD-9 code) y/n HEDIS manual Claims data Cohort definition HEDIS definition of persistent asthma 3: > 1 asthma-related hospitalization in 12 months Asthma-related inpatient visits (date, ICD-9 code) y/n HEDIS manual Claims data Cohort definition HEDIS definition of persistent asthma 4: > 1 asthma-related ED visits in 12 months Asthma-related ED visits (date, ICD-9 code) y/n HEDIS manual Claims data
  • 31. Rationale for Selection of Measures The current HEDIS measure for asthma uses administrative data collected during 1 year to identify patients with presumed persistent asthma and evaluates controller therapy during the next year. The current HEDIS asthma inclusion include a significant portion of patients with intermittent asthma;1, 2 thus, we chose to use the methods validated by Moser et al., who adapted the HEDIS measure to require at least 2 consecutive years meeting qualification criteria to identify persistent asthma.3 1 Kozyrskyj AL, Mustard CA, Becker AB. Identifying children with persistent asthma from health care administrative records. Can Respir J. 2004;11:141-145. 2 Cabana MD, Slish KK, Nan B, Clark NM. Limits of the HEDIS criteria in determining asthma severity for children. Pediatrics. 2004;114:1049-1055. 3 Mosen DM, Macy E, Schatz M, et al. How well do the HEDIS asthma inclusion criteria identify persistent asthma? Am J Manag Care. 2005 Oct;11(10):650-4.
  • 32. Outline for Systematic Identification of Data Domains and Elements • Review – Hypotheses and research questions – Cohort definition – Outcome measures – Primary explanatory variable – Covariates – Other future directions • Review these in order to – Make a list of needed data elements for current work – Lay the groundwork for future directions
  • 33. Outcome Measures • Patient-Reported Control Measures • Utilization Measures • Health-Related Quality-of-Life (HRQoL) PROCESSES OF CARE (clinician factors) + STRUCTURES OF CARE (system factors) + PATIENT FACTORS → OUTCOMES (chronic disease control)
  • 34. • Asthma Control Test (ACT) (Nathan et al. 2004) • Childhood Asthma Control Test (Liu et al. 2007) • Asthma Control Questionnaire (Juniper et al. 1999) • Asthma Therapy Assessment Questionnaire (ATAQ) control index (Vollmer et al. 1999) – mentioned in Research Design Patient-Reported Control Measures
  • 35. Outcome Measures: Utilization Measures • Ratio of controller to total asthma medications— mentioned in Research Design – > 0.5 is suggested cut-point – better associated with utilization (ED visits) than is HEDIS outcome measure – Weighted vs. not • HEDIS outcome measure – prescription of at least one controller medication – found to be more of a severity indicator than quality/control measure • Acute hospital visits (ED, inpatient)
  • 36. Outcome Measures: HRQoL • Asthma-Specific Quality of Life – Mini Asthma Quality of Life Questionnaire (Juniper et al. 1999a) – Asthma Quality of Life Questionnaire (Katz et al. 1999; Marks et al. 1993) – ITG Asthma Short Form (Bayliss et al. 2000) – Asthma Quality of Life for Children (Juniper et al. 1996) – Others? • Generic Quality of Life – SF-36 (Bousquet et al. 1994) – SF-12 (Ware et al. 1996)
  • 37. Data Elements for Outcome Measures Definition Construct Measure Elements Values Reference Data Source Asthma control Childhood Asthma Control Test 7 components 0-27 (poor control <19) Liu et al. 2007 POC measure Asthma control Ratio of controller to total asthma medications Asthma medication dispensed (date, medication) 0-1 (dichot omize at 0.5) HEDIS manual Claims data Asthma control Acute hospital resource utilization Asthma-related inpatient visits (date, ICD-9 code) # visits Claims data Asthma control Acute hospital resource utilization Asthma-related ED visits (date, ICD-9 code) # visits Claims data
  • 38. Rationale for Selection of Measures
  • 39. Outline for Systematic Identification of Data Domains and Elements • Establish: – Hypotheses and research questions – Cohort definition – Outcome measures – Primary explanatory variable – Covariates • Establish these in order to: – Make a list of needed data elements for current work – Lay the groundwork for future directions • Document a rationale for hypotheses and selection of measures (constructs and data elements)
  • 40. Primary Explanatory Variable • Clinical inertia: “the failure of clinicians to initiate or intensify drug therapy appropriately in a patient with uncontrolled asthma, blood pressure or cholesterol” CLINICAL INERTIA PROCESSES OF CARE (clinician factors) + STRUCTURES OF CARE (system factors) + PATIENT FACTORS → OUTCOMES (chronic disease control)
  • 41. Guideline-concordant intensification steps • Intensify = follow EPR3 steps • Uncontrolled = based on POC control test (ACT, ATAQ, etc)
  • 42. Data Elements for Primary Explanatory Variable Definition Construct Measure Elements Values Reference Data Source Clinical inertia Childhood Asthma Control Test 7 components, date 0-27 (poor control <19) Liu et al. 2007 POC measure Clinical inertia Medications Asthma medication dispensed (date, medication) Claims data
  • 43. Rationale for Selection of Measures ???
  • 44. Outline for Systematic Identification of Data Domains and Elements • Establish: – Hypotheses and research questions – Cohort definition – Outcome measures – Primary explanatory variable – Covariates • Establish these in order to: – Make a list of needed data elements for current work – Lay the groundwork for future directions • Document a rationale for hypotheses and selection of measures (constructs and data elements)
  • 45. Covariates • Processes of Care – Clinical inertia (primary explanatory variable) – Medication prescription • Structures of Care – Practice demographics – PCMH, IMH PROCESSES OF CARE (clinician factors) + STRUCTURES OF CARE (system factors) + PATIENT FACTORS → OUTCOMES (chronic disease control) • Patient Factors – Demographics, access – Co-morbidity (medical, mental health) – Severity of illness – Therapy adherence
  • 46. Covariates • Processes of Care – Clinical inertia (primary explanatory variable) – Medication prescription • Structures of Care – Practice demographics – PCMH, IMH PROCESSES OF CARE (clinician factors) + STRUCTURES OF CARE (system factors) + PATIENT FACTORS → OUTCOMES (chronic disease control) • Patient Factors – Demographics, access – Co-morbidity (medical, mental health) – Severity of illness – Therapy adherence
  • 47. Covariates • Medical Comorbidity: – “Chronic medical co-morbidity will be...grouped into 30 comorbidities as described by Elixhauser and Quan.” (AHRQ co-morbidity measures) – Body Mass Index (do we need other measures for children?) – Smoking status (also 2nd hand smoke exposure?) PROCESSES OF CARE (clinician factors) + STRUCTURES OF CARE (system factors) + PATIENT FACTORS → OUTCOMES (chronic disease control) Comorbidity
  • 49. Data Elements for Comorbidity Variable Definition Construct Measure Elements Values Reference Data Source Medical co- morbidity HCUP comorbidity measure ICD-9 codes from encounters and problem list 0-27 (poor control <19) Liu et al. 2007 EHR
  • 51. Disease-specific discussions • Hypertension • Hyperlipidemia • Asthma (Peds) • Asthma (Adults)
  • 52. Outline for Systematic Identification of Data Domains and Elements • Establish: – Hypotheses and research questions – Cohort definition – Outcome measures – Primary explanatory variable – Covariates • Establish these in order to: – Make a list of needed data elements for current work – Lay the groundwork for future directions • Documenting a rationale for hypotheses and selection of measures (constructs and data elements)
  • 57. Structures of Care • PCMH • IMH
  • 58. Patient Centered Med Home Standards- NCQA 1. Access and Communication 2. Patient Tracking and Registry Functions 3. Care Management 4. Patient Self‐Management Support 5. Electronic Prescribing 6. Test Tracking 7. Referral Tracking 8. Performance Reporting and Improvement 9. Advanced Electronic Communications
  • 61. System Level Factors • Applied differently based on patient/family/doctor-- can we account for this or not??
  • 62. Considerations for Future Research Asthma: • Asthma epidemiology has focused on individual- level and family risk factors. • Less focus on social and environmental context. • Low-income individuals more likely to be exposed to irritants, pollutants, indoor allergens, and psychosocial stress, which may influence asthma morbidity. • Future vision: enhance our cohort with data on suspected biological and environmental determinants of asthma disparities.
  • 63. Considerations for Future Research Hypertension: • Prevalence and rate of diagnosis of hypertension in children and adolescents are increasing, due in part to the increasing obesity prevalence and growing awareness of hypertension. • Future vision: expand our cohort to include adolescents with hypertension in an effort to identify health care delivery strategies appropriate for the lifespan of patients with hypertension.
  • 64. Considerations for Future Research Hypercholesterolemia: • American Academy of Pediatrics recommends screening overweight children with a fasting lipid profile • Rising obesity epidemic in U.S. children • Future vision: expand our hypercholesterolemia cohort to include overweight children.

Editor's Notes

  1. Here are the data elements for one measure—the HEDIS measure—for the cohort definition construct. The HEDIS measure for persistent asthma has four components, each with 1-2 component elements.
  2. To help illustrate the processes involved in constructing cohorts and associated data elements, we will run through a hypothetical hypothesis for an asthma cohort.
  3. Would also need to include rationale for hypothesis
  4. The cohort definition is meant to capture patients with persistent asthma. There are several options proposed in the Research Design and in other sources for how to define a cohort of patients with persistent asthma. These are summarized here, and shown in slightly more detail on the next 2 slides.
  5. Here are the data elements for one measure—the HEDIS measure—for the cohort definition construct. The HEDIS measure for persistent asthma has four components, each with 1-2 component elements.
  6. Here is a sample rationale-statement for the selection of one measure: the 2-consecutive-year version of the HEDIS definition of persistent asthma
  7. There are several options proposed in the Research Design and in other sources for how to define outcomes indicative of asthma control. These are summarized here, and shown in slightly more detail on the next 3 slides. We would need to select from these (and other) measures.
  8. This list includes some of the pt-reported control measures; we would select one of these for implementation at the POC. We would need to provide a rationale for the selection.
  9. There are several measures of asthma control based on healthcare resource utilization; this slide is a partial list.
  10. HRQoL is another construct that would fall into the Outcome Measures category. We would need to determine whether we will be using a disease-specific measure or a general measure for all cohorts, and then provide rationale for the specific selection
  11. These are data elements needed for a few of the asthma-related outcome measures
  12. As this is only an example we will not provide rationale statements for each type of data element
  13. Our primary explanatory variable is clinical inertia; this slide shows the definition from the Research Design.